si:ch211-248e11.2 Antibody

What is si:ch211-248e11.2 and what is its significance in zebrafish research?

Si:ch211-248e11.2 belongs to a class of zebrafish genes identified through genome sequencing projects, where the "si:ch" prefix denotes genes discovered during systematic chromosome mapping initiatives. This naming convention is common in zebrafish genetics for genes awaiting full functional characterization. Similar to other si:ch-prefixed genes (such as si:ch211-248e11.3, which is orthologous to human formin-binding protein 1), si:ch211-248e11.2 likely has structural or functional importance in zebrafish development . The antibody against this target provides researchers with a valuable tool for studying protein localization, expression patterns, and functional analyses in zebrafish models.

What are the common applications for si:ch211-248e11.2 antibody in zebrafish research?

The antibody is primarily used for:

• Immunohistochemistry (IHC) to visualize protein expression patterns in tissue sections

• Immunofluorescence (IF) for subcellular localization studies

• Western blotting for protein expression quantification

• Immunoprecipitation (IP) for protein-protein interaction studies

• Chromatin immunoprecipitation (ChIP) if the protein has DNA-binding properties

These applications allow researchers to characterize the spatial and temporal expression patterns of the protein during zebrafish development, similar to the approaches taken with other zebrafish proteins like those in the intermediate filament family .

How should si:ch211-248e11.2 antibody be validated before experimental use?

Proper validation should include:

• Western blot analysis showing a band of expected molecular weight

• Positive and negative control tissues based on known expression patterns

• Peptide competition assays to confirm specificity

• Testing in knockout or knockdown models (if available)

• Cross-reactivity assessment with closely related proteins

For zebrafish-specific antibodies, validation using CRISPR/Cas9 knockout models has become increasingly important, as demonstrated with other zebrafish proteins. This approach helps confirm antibody specificity, especially given the genome duplication events in teleost fish that can create paralogs with high sequence similarity .

What are the optimal fixation protocols for si:ch211-248e11.2 antibody in zebrafish tissue immunostaining?

Optimal fixation depends on the cellular localization of si:ch211-248e11.2. Based on similar intermediate filament proteins in zebrafish:

If si:ch211-248e11.2 is predicted to localize to intermediate filaments like other similar proteins, TCA fixation may preserve epitopes better than PFA alone . For dual immunostaining with other markers, fixation protocols should be optimized to maintain epitope accessibility for both antibodies.

How can I troubleshoot non-specific binding when using si:ch211-248e11.2 antibody in zebrafish tissues?

Non-specific binding can be addressed through:

• Increased blocking time: Extend from standard 1 hour to 3-4 hours using 5-10% normal serum

• Alternative blocking agents: Try fish gelatin (2-5%) instead of BSA for zebrafish tissues

• Antibody pre-adsorption: Incubate antibody with zebrafish tissue powder from unrelated tissues

• Titration optimization: Test dilution series (1:100 to 1:2000) to find optimal signal-to-noise ratio

• Detergent modification: Adjust Triton X-100 concentration (0.1-0.5%) to improve accessibility while maintaining tissue integrity

For zebrafish-specific proteins like si:ch211-248e11.2, batch-to-batch variability in antibodies can significantly impact specificity. Maintaining consistent validation protocols for each new lot is crucial for reproducible results .

What are the most effective immunoprecipitation conditions for studying si:ch211-248e11.2 protein interactions?

Effective immunoprecipitation typically requires:

• Lysis buffer optimization:

  • For cytoskeletal proteins: RIPA buffer with 1% NP-40, 0.5% sodium deoxycholate

  • For membrane-associated proteins: Buffer with 1% digitonin or 1% Triton X-100

  • Include phosphatase inhibitors if studying phosphorylation states

• Cross-linking considerations:

  • Use DSP (dithiobis[succinimidyl propionate]) for transient interactions

  • Formaldehyde (0.1-1%) for DNA-protein complexes if applicable

• Antibody coupling method:

  • Direct coupling to magnetic beads improves signal-to-noise ratio

  • Use of protein A/G beads may introduce heavy chain interference in subsequent blotting

The approach should be tailored based on the predicted subcellular localization of si:ch211-248e11.2, similar to approaches used for other zebrafish proteins with intermediate filament domains .

How do I optimize Western blot conditions for detecting si:ch211-248e11.2 protein in zebrafish samples?

Optimization should address:

If working with embryonic tissues, developmental stage-specific optimization may be necessary, as protein expression levels can vary dramatically across developmental timepoints .

What controls are essential when using si:ch211-248e11.2 antibody for immunofluorescence in zebrafish embryos?

Essential controls include:

• Negative controls:

  • Secondary antibody only (to detect non-specific binding)

  • Pre-immune serum (if available)

  • CRISPR/Cas9 knockout or morpholino knockdown tissue

  • Competing peptide block

• Positive controls:

  • Tissues with known expression based on in situ hybridization data

  • Overexpression systems (mRNA injection or transgenic lines)

• Specificity controls:

  • Co-staining with mRNA probes in fluorescent in situ hybridization

  • Comparison with GFP-tagged fusion protein localization

• Technical controls:

  • Autofluorescence assessment (particularly in yolk and pigmented cells)

  • Co-staining with established markers (e.g., DAPI for nuclei)

Similar to approaches used for cd79a (formerly si:ch211-64k10.2), validation in multiple tissue contexts is essential to confirm antibody specificity across different cellular environments .

How can RNA-seq data complement antibody-based detection of si:ch211-248e11.2?

RNA-seq data can provide:

• Expression validation: Confirm protein detection corresponds with mRNA expression patterns

• Developmental timeline: Map temporal expression changes to inform optimal sampling timepoints

• Splice variant identification: Detect potential isoforms that may react differently with antibodies

• Comparative expression analysis: Identify co-expressed genes for pathway analysis

• Knockdown validation: Confirm efficacy of genetic manipulations at the transcript level

Integrating RNA-seq with antibody-based detection creates a more comprehensive understanding of gene function. For zebrafish genes like si:ch211-248e11.2, RNA-seq can reveal tissue-specific expression patterns that guide more targeted antibody-based studies .

How can CRISPR/Cas9 gene editing be used to validate si:ch211-248e11.2 antibody specificity?

CRISPR/Cas9 validation involves:

• Design of guide RNAs targeting early exons to create frameshift mutations

• Generation of F0 mosaic embryos for preliminary antibody testing

• Establishment of stable knockout lines with confirmed mutations

• Western blot analysis comparing wild-type and knockout samples

• Immunohistochemistry comparison between wild-type and knockout tissues

• Quantitative assessment of signal reduction in knockout samples

This approach has been successfully used for validating antibodies against other zebrafish proteins. For genes like si:ch211-248e11.3, which has two available nonsense alleles (sa21213 and sa34330), similar resources may be available for si:ch211-248e11.2 through the Zebrafish Mutation Project .

What are the considerations for using si:ch211-248e11.2 antibody in multi-color immunofluorescence with other zebrafish markers?

Key considerations include:

• Antibody compatibility: Ensure primary antibodies are raised in different host species

• Sequential staining protocols: Consider implementing for antibodies from the same species

• Spectral overlap management: Select fluorophores with minimal bleed-through

• Fixation compromise: Choose fixation that preserves all target epitopes

• Antigen retrieval optimization: Balance conditions for multiple targets

• Order of antibody application: Test different sequences to maximize signal quality

When combining with common zebrafish markers, start with established protocols for those markers and adapt conditions for si:ch211-248e11.2 antibody. Similar to strategies used for other zebrafish intermediate filament proteins, careful titration of each antibody in the multiplex panel is essential for optimal results .

How reliable are commercial si:ch211-248e11.2 antibodies for cross-species application?

Cross-species applicability depends on:

• Sequence conservation: Homology between target epitopes across species

• Validation evidence: Published cross-reactivity data from antibody manufacturers

• Immunogen design: Antibodies raised against conserved domains have higher cross-reactivity potential

• Application-specific testing: Cross-reactivity may vary between Western blot and immunohistochemistry

For zebrafish-specific proteins like si:ch211-248e11.2, cross-reactivity with mammalian orthologs should be experimentally verified. If si:ch211-248e11.2 has human orthologs similar to si:ch211-248e11.3 (which is orthologous to human FNBP1), sequence alignment of the immunogen region with the human counterpart can predict potential cross-reactivity .

What quantification methods are appropriate for si:ch211-248e11.2 immunofluorescence in zebrafish tissues?

Appropriate quantification methods include:

For developmental studies, stage-matched controls are essential, as baseline expression can vary significantly across developmental timepoints. Statistical analysis should account for inter-embryo variability, typically requiring 15-20 embryos per condition across 3+ independent experiments .

How should researchers address conflicting results between mRNA expression and si:ch211-248e11.2 antibody detection?

When facing discrepancies:

• Verify temporal dynamics: Protein expression may lag behind mRNA expression

• Consider post-transcriptional regulation: miRNAs may suppress translation despite high mRNA levels

• Examine protein stability: Long protein half-life may persist despite decreased transcription

• Check antibody specificity: Confirm antibody detects all relevant isoforms

• Assess detection sensitivity: RNA detection methods may be more sensitive than antibody-based methods

• Evaluate spatial resolution: Whole-tissue RNA extraction may mask cell-type-specific differences

For zebrafish proteins, differences between transcript and protein abundance are commonly observed during rapid developmental transitions. Integrating multiple detection methods provides the most comprehensive understanding of gene expression dynamics .

What bioinformatic resources can help predict si:ch211-248e11.2 protein interactions for immunoprecipitation studies?

Useful bioinformatic resources include:

• STRING database: Predicts functional protein associations based on genomic context

• ZFIN expression database: Identifies co-expressed genes in zebrafish

• Protein domain analysis tools: Predicts interaction motifs based on conserved domains

• Ortholog interaction maps: Leverages known interactions of mammalian orthologs

• BioGRID: Curates protein and genetic interactions from published experimental data

Domain analysis of si:ch211-248e11.2 may reveal structural similarities to better-characterized proteins, such as intermediate filament family members or formin-binding proteins, providing hypotheses for potential interaction partners to test in co-immunoprecipitation experiments .